Masonic Cancer Center

A comprehensive cancer center designated by the National Cancer Institute

Funding Opportunities

Extramural Grant Review Opportunity Available

Writing a grant? Need another set of eyes?

The Masonic Cancer Center Science Council can appoint individuals to review cancer center faculty members' grant drafts* or grant ideas in a face-to-face setting or in writing, depending on the stage of grant development. The goal is to improve upon members' success in obtaining grants funded by the NCI, ACS, and other national cancer research organizations.

To request a review, contact Aaron Schilz, schil226@umn.edu, 624-0650.

*Members should submit their ideas or abstracts and specific aims one cycle (~3-4 months minimum) before the grant is due. We will usually provide feedback within 1 week.


News and Notices 

News & Notices:

New NIH Genomic Data Sharing Policy
(NOT-OD-14-124)
Office of the Director, NIH

Piloting Modified NIH Biosketches

(NOT-OD-14-091)
National Institutes of Health
The new Biosketch format being piloted will extend the page limit from four to five pages and it will allow researchers to describe up to five of their most significant contributions to science along with the historical background that framed their research.

NIH Announces Significant Change in Policy for Application Submissions
(NOT-OD-14-074)
National Institutes of Health

NIH Issues 2014 Funding Levels
Non-competing continuation awards that have already been made in FY 2014 were generally funded at levels below that indicated on the most recent Notice of Award (generally up to 90% of the previously committed level). Such reductions may be fully or partially restored, depending on the Institute or Center. Non-competing continuation grants (research and non-research) including those that remain to be issued in FY 2014 likely will be made within the range between the commitment level indicated on the Notice of Award and 3 percent below that level.

NIH Publication Compliance and RPPR Progress Reports (PDF)
Click on the title of this notice for a PDF containing a list of several helpful resources for navigating, monitoring, and managing publication compliance. For more information or questions, please contact Aaron Schilz, Research Grant Coordinator, schil226@umn.edu.

NIH Salary Cap increases to $181,500 Effective January 14, 2014
By Executive Order 13655

Funding Opportunities 

Sarcoma Research Grant
Karen Wyckoff Rein In Sarcoma Foundation Grant 2015
Application Deadline: November 24, 2014
Funding: Up to $50,000

Training Modules to Enhance Data Reproducibility (R25)
(RFA-GM-15-006)
National Cancer Institute
Application Receipt Date(s): November 20, 2014
Funding: $150,000 for up to 5 years

Advancing Interventions to Improve Medication Adherence
PA-14-334 – R01
PA-14-335 – R21
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
Funding: Standard R01 & R21 limit

Role of the Microflora in the Etiology of Gastro-Intestinal Cancer (R01)
(PAR-14-242)
National Cancer Institute
Application Receipt Date(s): November 4, 2014; March 3, 2015; See announcement for additional dates.
Funding: Standard R01 limits apply.

Interventions for Health Promotion and Disease Prevention in Native American Populations (R01)
(PAR-14-260)
National Cancer Institute
Application Receipt Date(s): May 12, 2015, May 12, 2016, See announcement for additional dates.
Funding: Standard R01 limits apply.

Exploratory Studies of Smoking Cessation Interventions for People with Schizophrenia (R21/R33)
(PAR-14-230)
National Cancer Institute
Application Receipt Date(s): December 16, 2014, April 15, 2015, August 17, 2015, December 15, 2015. See announcement for additional deadlines.
Funding: The R21 phase may not exceed two years or $275,000 in direct costs, with no more than $150,000 in direct costs in any single year of the R21 phase.  The R33 phase may not exceed three years or $450,000 in direct costs, with no more than $225,000 in direct costs in any single year of the R33 phase.

Exploratory Studies of Smoking Cessation Interventions for People with Schizophrenia (R21/R33)
(PAR-14-230)
National Cancer Institute
Application Receipt Date(s): December 16, 2014, April 15, 2015, August 17, 2015, December 15, 2015. See announcement for additional deadlines.
Funding: The R21 phase may not exceed two years or $275,000 in direct costs, with no more than $150,000 in direct costs in any single year of the R21 phase.  The R33 phase may not exceed three years or $450,000 in direct costs, with no more than $225,000 in direct costs in any single year of the R33 phase.

Predoctoral Training in Biomedical Big Data Science (T32)
(RFA-HG-14-004)
National Cancer Institute
Application Receipt Date(s): July 27, 2015, by 5:00 PM local time of applicant organization.
Funding: Average size budget of $350,000/yr total costs for 5 years

Genomic Resource Grants for Community Resource Projects (U41)
(PAR-14-191)
National Cancer Institute
Application Receipt Date(s):  January 25, 2015; May 25, 2015; September 25, 2015; January 25, 2016; May 25, 2016; September 25, 2016; January 25, 2017 
Funding: 5 years of funding.  Application budgets are not limited, but should reflect the needs of the proposed project.

THE U OF M INFORMATICS INSTITUTE (UMII) has announced two major funding initiatives at the interface of informatics and its applications: the UMII Transdisciplinary Research Fellowship will position recently promoted associate professors to provide leadership in transdisciplinary collaborative projects, and the UMII Faculty in Industry Fellowship will enable faculty to build strong partnerships with Minnesota businesses or agencies to develop long-term projects that address critical societal challenges. For more information, see UMII .

Behavioral Interventions to Address Multiple Chronic Health Conditions in Primary Care (R01)
(PA-14-114)
National Cancer Institute
Funding: Standard R01 limits apply.
Application Receipt Date(s): Multiple dates, see announcement.

Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R21)
(PAR-14-013)
National Cancer Institute
Funding: Standard R21 limits apply
Deadline: See announcement for dates.

Quantitative Imaging for Evaluation of Response to Cancer Therapies (U01)
(PAR-14-116)
National Cancer Institute
Funding: $500,000/yr for 5 years
Application Receipt Date(s): Multiple dates, see announcement

Funding for High-Impact Pediatric Cancer Research
Sponsor: Solving Kids’ Cancer Foundation
Clinical Idea of Intent Deadline: open-ended (through 2014 calendar year)
Proposal Deadline: notification to fully submit will occur 5 weeks after intent submisison
Amount: $50,000 - $600,000 depending on scope

Modeling Social Behavior (R01)
(PAR-13-374)
National Cancer Institute
Deadline: Multiple dates, see announcement.
Funding: Standard R01 limits apply.

Nutrigenetics and Nutrigenomics Approaches for Nutrition Research (R01)
(PAR-13-375)
National Cancer Institute
Deadline:  March 19, 2015; March 22, 2016
Funding: Standard R01 limits apply.

TTR Core Usage Funding Program
Sponsor: Office of Discovery and Translation - CTSI
Application Deadline (ongoing): 5 p.m. on the 10th day of any month
Funding: up to $10,000 to use a TTR-designated Core Resource for up to one year
The Core Usage Funding Program is designed to support clinical or translational projects. Basic research projects are ineligible. The supported studies may be either pilot projects, intended to generate preliminary data for larger studies, or projects nearing the final stages of completion but now require additional data the Core Resources can generate. It is expected that a Core Usage grant will be used to generate data to support an external grant submission or patent application.

Pancreatic Cancer Action Network Research Grants Program
Sponsor: Pancreatic Cancer Action Network and American Association for Cancer Research
Deadlines: Multiple; see announcement
Funding: See announcement
Funding is available for postdoctoral/clinical research fellows as well as for junior and senior independent researchers. The proposed research must be directly relevant to pancreatic cancer. More information about the grants program, including eligibility criteria and application due dates and procedures, is available at http://www.pancan.org/2014grants..

Research to Characterize and Reduce Stigma to Improve Health
R01 (PA-13-248)
R03 (PA-13-247)
R21 (PA-13-246)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.  Standard cycle dates.
Funding: Standard limits apply

Tobacco Control Regulatory Research
R01 (RFA-OD-13-011)
R03 (RFA-OD-13-012)
R21 (RFA-OD-13-010)
U.S. Food and Drug Administration, Center for Tobacco Products
National Cancer Institute
Application Receipt Date:January 16, 2015
Funding: R01 - $499,999 direct costs per year; standard limits for R03 and R21 applications.

Prostate Cancer Research Program (PCRP)
Sponsor: Department of Defense
Deadlines: Various; see announcements
Funding: See announcements

Innovative Research Methods: Prevention and Management of Symptoms in Chronic Illness
R01 (PA-13-165)
R15 (PA-13-166)
R21 (PA-13-167)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
Funding: Standard limits apply. See announcements for additional information.

Bioengineering Research Grants (BRG) (R01)
(PAR-13-137)
National Cancer Institute
Application Deadline: Multiple receipt dates, see announcement. 
Funding: Standard R01 limits apply

Academic-Industrial Partnerships for Translation of in vivo Imaging Systems for Cancer Investigations (R01)
(PAR-13-169)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
Funding: standard R01 limits apply

Research Funding Resources
  • ©2014 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer
  • Last modified on October 30, 2014